Skip to content
Search

Latest Stories

North Somerset pharmacy pioneers into automation with robotics

A North Somerset community pharmacist Hussein Almosawi is planning to venture into care home sector after pioneering into automation and robotics technology, generating 50 per cent efficiency savings.

Almosawi is chief executive officer of SmartPharm, a chain of pharmacies having businesses in Clevedon, Brentford and in East London.


After taking over the Clevedon branch in January this year he installed the Titan pharmacy operating system, from Invatech Health in Bristol.

With its cloud-based architecture, Titan allows full integration with other systems –including robots – that helps in creating a unique workflow.

Almosawi’s practice is the first in the UK to integrate Titan with the Vmax medication dispensing robot, from German manufacturer BD Rowa.

Almosawi said the use of new technology has brought a massive change in the practice and the community it serves, making the functioning much “smoother, easier and more efficient.”

He added: “It’s certainly taken the pressure off our staff. They’re enjoying work and life’s not as busy or stressful as it used to be. We no longer have queues stretching around the premises, with people waiting outside in all weathers.

“We’re actually now working at under our full capacity. So we’re looking at launching into care homes without increasing our staff numbers. We can dispense more prescriptions, offer other services and explore new avenues for our business.”

After its launch in late 2019, Titan became the first pharmacy dispensing system to get NHS accreditation in more than a decade. It created the first paperless workflow and the first barcode scanning process, helping free up pharmacists’ time and enabling them to focus on newly commissioned patient services.

Earlier this year, Invatech Health announced a further £950,000 funding from Innovate UK, under a programme to support game-changing innovations in the UK’s SME community.

The company has created cloud platform and API messaging to allow other systems to connect with the PMR workflow. This integration is equivalent to an ‘app store’ for pharmacy.

Tariq Muhammad, CEO at Invatech Health, said: “We always planned to have integrations with robots and we saw this as an exciting opportunity to take dispensing workflow to the next level and be more than just a simple message communicating to the robot. We’re extremely pleased with the impact our tech is having.”

Besides, the new Titan Stock app was released to SmartPharm Pharmacy earlier this month.

The special feature of the app is that it solves the issue of split packs. This is when the doctor prescribes a quantity which is less than the original pack size of the drug. In such cases, Titan issues a new barcode to identify the leftover stock so it can be recognised by the robot as a split.

Joshua Akin-George, Sales Leader BD Rowa™ Northern Europe, said Titan’s approach to the integration is refreshing and allows the full potential of the V-Max to be realised.

He said: “The combined effect of our joint interface, the Titan Stock App and the established digital and paperless workflow already in Titan, has given rise to a new level of efficiency never before seen in a pharmacy.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less